Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

On July 2, linvoseltamab-gcpt (Lynozyfic; Regeneron) received an accelerated approval from the FDA in relapsed/refractory ...

Larazotide, a therapy known to treat celiac disease, shows promise as a safe treatment for multisystem inflammatory syndrome in children linked to COVID-19, enhancing recovery and symptom resolution.

Yonker is a co-inventor on a patent for zonulin antagonists to treat MIS-C, as are two other co-authors. Co-authors also ...

There have been lots of changes to COVID vaccine recommendations. Here is the current vaccine schedule for people 6 months to ...

In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more ...

The diagnosis: COVID-19, an illness that she had managed to avoid for more than two years since it first started spreading in the U.S. in early 2020. Given an underlying health condition — Mesa was ...

Bay Area researchers created a group of AI “scientists” that proposed a potential COVID treatment. They say the approach ...

Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.

COVID symptoms this summer look a lot like symptoms from earlier strains, such as fatigue, runny nose and a headache. “The ...

The interview with Dr Asad Khan on long Covid (Solidarity 747-748) highlights the contribution to the growth in mental ill-health of widespread long Covid, which affects hundreds of millions of ...